1 Min Read
May 1 (Reuters) - Aptevo Therapeutics Inc:
* APTEVO THERAPEUTICS INC - ON TRACK TO COMMENCE PHASE 1 CLINICAL TRIAL OF APVO436 IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN Q4 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.